Both in Biotechnology
Amgen vs Exelixis
Over the past year AMGN returned +57.1% and EXEL returned +84.3%; their daily moves had a correlation of 0.46.
AMGN +57.1% EXEL +84.3%Growth of $1, one year, split-adjusted
| Metric | AMGN | EXEL |
|---|---|---|
| Price | $465.45 | $70.13 |
| Market cap | $251.64B | $17.11B |
| Today | −0.12% | +1.07% |
| 1 month | +15.5% | +20.1% |
| 6 months | +43.7% | +58.8% |
| Year to date | +42.2% | +60.0% |
| 1 year | +59.4% | +80.1% |
| Revenue growth (YoY) | +9.5% | +10.2% |
| Gross margin | 72.0% | 96.0% |
| Net margin | 23.6% | 33.1% |
| P/E (TTM) | 28.8× | 19.3× |
| Price / sales | 6.6× | 6.9× |
| Net cash | -$43.31B | $892.0M |
| Dividend yield | 2.17% | — |
| Volatility (60d) | 33.1% | 26.8% |
| Short % of float | 2.5% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).